Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.98 is 32% above its 5-year average of 0.74, near the low end of its 5-year range (0.14–4.31).
As of the fiscal period ended Tuesday, June 30, 2026. 59.79% below its 12-month average of 2.44.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.98.
CURRENT RATIO
0.98
CURRENT RATIO AVG TTM
2.44
CURRENT RATIO AVG 3Y
1.14
CURRENT RATIO AVG 5Y
0.74
CURRENT RATIO AVG 10Y
0.53
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-59.79%
CURRENT VS 3Y AVG
-13.99%
CURRENT VS 5Y AVG
+31.97%
CURRENT VS 10Y AVG
+84.08%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.34
median of 516 covered companies
CURRENT VS SECTOR MEDIAN
-70.65%
vs the sector median at left
BioStem Technologies, Inc.
Market Cap
$46.88M
Current Ratio
0.98
TTM Avg
2.44
3Y Avg
1.14
5Y Avg
0.74
Market Cap
$45.68M
Current Ratio
2.91
TTM Avg
4.54
3Y Avg
5.51
5Y Avg
8.87
Market Cap
$42.95M
Current Ratio
2.08
TTM Avg
2.23
3Y Avg
2.23
5Y Avg
2.23
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | $46.88M | 0.98 | 2.44 | 1.14 | 0.74 |
| Lite Strategy, Inc. (LITS)vs › | $47.64M | 5.74 | 9.62 | 7.35 | 7.40 |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.68M | 2.91 | 4.54 | 5.51 | 8.87 |
| Celularity Inc. (CELU)vs › | $49.21M | 0.09 | 0.27 | 0.34 | 1.05 |
| biote Corp. (BTMD)vs › | $49.40M | 1.43 | 1.27 | 3.36 | 3.09 |
| Clene Inc. (CLNN)vs › | $49.84M | 3.07 | 1.20 | 1.51 | 3.42 |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.95M | 2.08 | 2.23 | 2.23 | 2.23 |
| Apollomics, Inc. (APLM)vs › | $51.17M | 0.96 | 1.17 | 2.45 | 5.02 |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 3.81 | 5.31 | 3.36 | 3.21 |
| DarioHealth Corp. (DRIO)vs › | $42.41M | 2.31 | 3.08 | 3.34 | 3.56 |
Current Ratio
0.98
Quick Ratio
0.76
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.98 |
| 2026-03-31 | 1.14 |
| 2025-12-31 | 4.12 |
| 2025-09-30 | 4.31 |
| 2025-06-30 | 1.64 |
| 2025-03-31 | 1.40 |
| 2024-12-31 | 1.35 |
| 2024-09-30 | 1.25 |
| 2024-06-30 | 1.22 |
| 2024-03-31 | 1.13 |
| 2023-12-31 | 0.81 |
| 2023-09-30 | 0.48 |
| 2023-06-30 | 0.18 |
| 2023-03-31 | 0.15 |
| 2022-12-31 | 0.23 |
| 2022-09-30 | 0.35 |
| 2022-06-30 | 0.44 |
| 2022-03-31 | 0.78 |
| 2021-12-31 | 0.14 |
| 2021-09-30 | 0.16 |
| 2021-06-30 | 0.27 |
| 2021-03-31 | 0.15 |
| 2020-12-31 | 0.13 |
| 2020-09-30 | 0.15 |
| 2020-06-30 | 0.17 |
| 2020-03-31 | 0.16 |
| 2019-12-31 | 0.18 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 0.37 |
| 2018-09-30 | 0.40 |
| 2018-06-30 | 0.26 |
| 2018-03-31 | 0.15 |
| 2017-12-31 | 0.21 |
| 2017-09-30 | 0.16 |
| 2017-06-30 | 1.56 |
| 2017-03-31 | 1.44 |
| 2016-12-31 | 0.88 |
| 2016-09-30 | 0.09 |
| 2016-06-30 | 0.17 |
| 2016-03-31 | 0.46 |
| 2015-12-31 | 0.99 |
| 2015-09-30 | 0.40 |
| 2015-06-30 | 0.31 |
| 2015-03-31 | 0.52 |
| 2014-12-31 | 0.25 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.02 |
| 2013-12-31 | 0.29 |
| 2013-09-30 | 3.14 |
| 2013-06-30 | 2.03 |
| 2013-03-31 | 2.54 |
